The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy-Reference-Cited by-同舟云学术

The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy

Published:2009-01 Issue:1 Volume:60 Page:290-298
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Jansen Nathalie W. D.,Roosendaal Goris,Lundin Björn,Heijnen Lily,Mauser-Bunschoten Evelien,Bijlsma Johannes W. J.,Theobald Matthias,Lafeber Floris P. J. G.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference42 articles.

1. Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review;Sumer;Biomarkers,2006

2. Type II collagen markers in osteoarthritis: what do they indicate?;Henrotin;Curr Opin Rheumatol,2007

3. Collagen type II C-telopeptide fragments as an index of cartilage degradation;Christgau;Bone,2001

4. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index;Mouritzen;Ann Rheum Dis,2003

5. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study;Garnero;Arthritis Rheum,2002

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stromal cell‐derived factor 1 alpha (SDF‐1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy;International Journal of Rheumatic Diseases;2024-02

2. Subclinical synovial proliferation in patients with severe haemophilia A: The value of ultrasound screening and biochemical markers;Haemophilia;2023-09-11

3. Poor correlation between biomarkers and MRI-detected joint damage in a cross-sectional study of persons with nonsevere hemophilia A (DYNAMO study);Journal of Thrombosis and Haemostasis;2023-07

4. Clinical and radiological assessment of joints in people with haemophilia in Assam, Northeast India: a cross-sectional study;The Journal of Haemophilia Practice;2023-01-01

5. How to assess, detect, and manage joint involvement in the era of transformational therapies: Role of point‐of‐care ultrasound;Haemophilia;2022-09-26